Garbay-Jaureguiberry C - Search Results

1

DNA sequence recognition by the antitumor drug ditercalinium.

Crow SD, Bailly C, Garbay-Jaureguiberry C, Roques B, Shaw BR, Waring MJ. Crow SD, et al. Among authors: garbay jaureguiberry c. Biochemistry. 2002 Jul 9;41(27):8672-82. doi: 10.1021/bi012207q. Biochemistry. 2002. PMID: 12093285

2

Tight binding of the antitumor drug ditercalinium to quadruplex DNA.

Carrasco C, Rosu F, Gabelica V, Houssier C, De Pauw E, Garbay-Jaureguiberry C, Roques B, Wilson WD, Chaires JB, Waring MJ, Bailly C. Carrasco C, et al. Among authors: garbay jaureguiberry c. Chembiochem. 2002 Dec 2;3(12):1235-41. doi: 10.1002/1439-7633(20021202)3:12<1235::AID-CBIC1235>3.0.CO;2-I. Chembiochem. 2002. PMID: 12465032 Free article.

3

DNA distortion in bis-intercalated complexes.

Peek ME, Lipscomb LA, Bertrand JA, Gao Q, Roques BP, Garbay-Jaureguiberry C, Williams LD. Peek ME, et al. Among authors: garbay jaureguiberry c. Biochemistry. 1994 Apr 5;33(13):3794-800. doi: 10.1021/bi00179a002. Biochemistry. 1994. PMID: 8142381

4

Acridine dimers: influence of the intercalating ring and of the linking-chain nature on the equilibrium and kinetic DNA-binding parameters.

Markovits J, Garbay-Jaureguiberry C, Roques BP, Le Pecq JB. Markovits J, et al. Eur J Biochem. 1989 Mar 15;180(2):359-66. doi: 10.1111/j.1432-1033.1989.tb14656.x. Eur J Biochem. 1989. PMID: 2924770 Free article.

5

Asymmetrical bisintercalators as potential antitumor agents.

Léon P, Garbay-Jaureguiberry C, Lambert B, Le Pecq JB, Roques BP. Léon P, et al. J Med Chem. 1988 May;31(5):1021-6. doi: 10.1021/jm00400a023. J Med Chem. 1988. PMID: 3283364

6

Relationship between the size and position of substituents on 7H-pyrido[4,3-c]carbazole monomers and dimers and their DNA binding and anti-tumor properties.

Léon P, Garbay-Jaureguiberry C, Le Pecq JB, Roques BP. Léon P, et al. Anticancer Drug Des. 1988 Jun;3(1):1-13. Anticancer Drug Des. 1988. PMID: 3382504

7

DNA bis-intercalators as new anti-tumour agents: modulation of the anti-tumour activity by the linking chain rigidity in the ditercalinium series.

Garbay-Jaureguiberry C, Laugâa P, Delepierre M, Laalami S, Muzard G, Le Pecq JB, Roques BP. Garbay-Jaureguiberry C, et al. Anticancer Drug Des. 1987 Apr;1(4):323-35. Anticancer Drug Des. 1987. PMID: 3450302

8

Asymmetry and dynamics in bis-intercalated DNA.

Peek ME, Lipscomb LA, Haseltine J, Gao Q, Roques BP, Garbay-Jaureguiberry C, Williams LD. Peek ME, et al. Among authors: garbay jaureguiberry c. Bioorg Med Chem. 1995 Jun;3(6):693-9. doi: 10.1016/0968-0896(95)00064-n. Bioorg Med Chem. 1995. PMID: 7582947

9

Comparison of the bis-intercalating complexes formed between either ditercalinium or a flexible analogue and d(CpGpCpG)2 or d(TpTpCpGpCpGpApA)2 minihelices: 1H- and 31P-NMR analyses.

Pothier J, Delepierre M, Barsi MC, Garbay-Jaureguiberry C, Igolen J, Le Bret M, Roques BP. Pothier J, et al. Biopolymers. 1991 Oct;31(11):1309-23. doi: 10.1002/bip.360311109. Biopolymers. 1991. PMID: 1777582

10

1H and 31P nuclear magnetic resonance studies of the differences in DNA deformation induced by anti-tumoral 7H-pyrido[4,3-c]carbazole dimers.

Delepierre M, Maroun R, Garbay-Jaureguiberry C, Igolen J, Roques BP. Delepierre M, et al. J Mol Biol. 1989 Nov 5;210(1):211-28. doi: 10.1016/0022-2836(89)90301-x. J Mol Biol. 1989. PMID: 2585517

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

37 results

Search Page